https://charts.traderzeitung.de/phases/US9286612067 string(1419) "{"isin":"US9286612067","name":"VolitionRX Ltd","stock_id_xnas":132475201,"stock_id_xnys":132475202,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.26,"close_at":"2026-09-21 21:58:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":0.264,"close_at":"2026-09-21 23:50:00","complete":true,"perf_pct":1.5385}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.258,"close_at":"2026-09-22 21:57:00","complete":true,"perf_pct":-2.2727},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.238,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-7.7519},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

VolitionRX Aktie News & Nachrichten

[WKN: A42AGG | Symbol: VNRX]

Realtimekurs

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über VolitionRX gefunden werden.

VolitionRX Nachrichtenticker öffnen

MT Newswires 28.08.2026 22:41 Uhr

VolitionRX Aktie News & Nachrichten

Artikel aus der Redaktion der Trader-Zeitung

VolitionRx beantragt Zweitangebot von Stammaktien

VolitionRx kooperiert mit Japans Sysmex zur Optimierung auf der Plattform

VolitionRx reicht Patent für Nu.Q NETs Test bei der Ebola-Triage und -Überwachung ein